
Meds Apotek stock
Last updated
Meds Apotek was founded in 2018 by Adham, Joanna and Björn, three entrepreneurs with extensive experience in the pharmacy industry and e-commerce. Headquartered in Stockholm, Meds is a full-scale digital pharmacy that sells prescription and over-the-counter medicines authorised by the Swedish Medical Products Agency. Meds has no physical stores but focuses on delivering products directly to customers as quickly as possible.
Note: Information on Meds Apotek is sourced from official channels and public sources unless otherwise stated.
Meds Apotek new issues and valuations
| Date | Type | Share price | Amount The specific amount raised in this funding round. | Valuation The company's valuation after the funding round was completed (Post-money). |
|---|---|---|---|---|
| Q2 2023 | 44 SEK | SEK 62,500,000 | SEK 759,100,000 | |
| Q2 2022 | 80 SEK | SEK 80,200,000 | SEK 1,262,300,000 | |
| Q1 2021 | 48.6 SEK | SEK 167,000,000 | SEK 763,000,000 |
Note: Information on Meds Apotek's funding rounds, amounts, and valuation is sourced from news media and public sources unless otherwise stated. Information on capital structure is sourced from public company registers unless otherwise stated.
About the company
Business description is not available at this time.
Major Shareholders in Meds Apotek
| Name | Shares | Capital % |
|---|---|---|
| M2 Asset Management AB | 2,513,550 | 14.6% |
| Coeli Wealth Management AB | 1,709,184 | 9.9% |
| Ilija Batljan Invest AB | 908,064 | 5.3% |
| Bjorn Thorngren | 693,441 | 4.0% |
Note: Information on Meds Apotek's ownership structure is sourced from public company registers and external data providers unless otherwise stated. Source: Eivora (9/5/2025).
Meds Apotek stock: key facts
Note: Information sourced from official company registrations and public sources unless otherwise stated.
Active market
Settlement follows an established process with third-party verification of payment and share transfer, minimizing counterparty risk for both parties.
Securities shown in the view above are for illustrative purposes only.
News about Meds Apotek
Meds Apotek vill fortsätta växa snabbare än marknaden - vd
Meds makes its stock market debut – this is how the first day went
Tuesday marked the stock market debut of online pharmacy Meds. The share price got off to a flying start when trading began, but then slowed down somewhat.

Meds Apotek Shares Surge 23 Percent in First North Debut
The pharmacy company Meds Apotek saw its shares soar in their debut trading session on First North this Tuesday.

Buy Meds Apotek shares
Place a bid on Meds Apotek shares. View historical prices and access unique company data.
Buy shares in Meds ApotekHelp for new buyers
Sell Meds Apotek shares
Unlock capital from your unlisted holding. Accumeo matches you with buyers and handles settlement through an established process.
Sell shares in Meds ApotekHelp for new sellers
Have any questions about buying or selling shares in private companies? Don't hesitate to contact us.
FAQ
Meds Apotek is an unlisted company, meaning the shares are not traded on any exchange. Instead, transactions take place through direct transfers between parties, known as secondary trading, typically via a specialised platform for unlisted shares such as Accumeo. For larger international companies, investing through fund structures that pool several investors into a single ownership vehicle is also common. This allows smaller minimum investments and opens up access to international companies for non-institutional investors.
Yes, it is possible to buy existing shares in Meds Apotek through secondary trading. On Accumeo you create a free account, submit an expression of interest with an amount and any conditions, and may then be matched with a seller. Once both parties have signed the customer agreement, a share transfer agreement is drawn up covering price, share count, and settlement date.
Yes, secondary trading is often the only realistic route to liquidity for an unlisted holding before an IPO or acquisition. Via Accumeo you submit an expression of interest with a share count and target price, and a match may be made with a potential buyer. The sale is executed through a share transfer agreement and registered either via Euroclear or directly in the company's share register, depending on how ownership is administered.
Unlisted companies have no continuous share price because there is no continuous exchange trading. The value is instead based on the latest secondary-market trade or on the price per share from the most recent share issuance. Accumeo shows both historical transaction prices and current bid/ask quotes, providing a combined reference point for pricing.
The value of an unlisted share is most often based on the latest trade — the price buyer and seller agreed in a transaction — or on the latest funding round, where the company and its investors agreed a price for the newly issued shares. These are the reference points shown on Accumeo's platform. It is, however, important to form your own view of value by examining the company's prospects. Financial reports, growth opportunities, market position, and comparable transactions in the sector all help to build a better picture of how the business may develop. Useful information can be found on the company's own website, via Accumeo's platform, and on services like allabolag.se.
No, Meds Apotek is an unlisted company and its shares are not traded on the Stockholm Stock Exchange, NYSE, or any other regulated marketplace. Shares are instead traded through secondary trading between investors, typically via a specialised platform such as Accumeo.
Disclaimer: The information in this FAQ is provided for informational purposes only and does not constitute an offer to buy or sell securities, a solicitation of such an offer, or investment advice. Accumeo has no commercial relationship with the companies whose securities are mentioned. Independent advice should be obtained before making any investment decision.
Other companies you may be interested in
Start exploring unlisted shares today
Join 5,000+ investors already trading unlisted shares. Create an account in 2 minutes with BankID — completely free.
-400x300.png&w=3840&q=75)






-400x300.png&w=3840&q=75)






